Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK1 | Q13464 | 15/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.54 |
| ▸ | RPS6KB1 | P23443 | 6/20 | 0.54 |
| ▸ | RPS6KA1 | Q15418 | 6/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.49 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.38 |
| ▸ | GRK2 | P25098 | 5/20 | 0.38 |
| ▸ | GRK5 | P34947 | 2/20 | 0.38 |
| ▸ | ACACB | O00763 | 1/20 | 0.38 |
| ▸ | ACACA | Q13085 | 1/20 | 0.38 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3884743 | 0.90 | ROCK1 (0.59) | ROCK1CYP3A4CYP2D6RPS6KB1RPS6KA1 | |
| SCHEMBL3884931 | 0.89 | ROCK1 (0.60) | ROCK1CYP3A4CYP2D6RPS6KB1RPS6KA1 | |
| SCHEMBL3860919 | 0.88 | ROCK1 (0.54) | ROCK1CYP3A4CYP2D6RPS6KB1RPS6KA1 | |
| SCHEMBL3885111 | 0.85 | ROCK1 (0.68) | ROCK1CYP3A4CYP2D6RPS6KB1RPS6KA1 | |
| SCHEMBL3893789 | 0.82 | ROCK1 (0.73) | ROCK1CYP3A4CYP2D6RPS6KB1RPS6KA1 | |
| SCHEMBL3885385 | 0.77 | ROCK1 (0.57) | ROCK1RPS6KB1RPS6KA1ROCK2GRK2 | |
| SCHEMBL4934586 | 0.77 | ROCK1 (0.74) | ROCK1CYP3A4CYP2D6RPS6KB1RPS6KA1 | |
| SCHEMBL3887046 | 0.77 | JAK2 (0.40) | ROCK1CYP3A4CYP2D6RPS6KB1RPS6KA1 | |
| SCHEMBL3887155 | 0.77 | LRRK2 (0.43) | ROCK1CYP3A4CYP2D6RPS6KB1RPS6KA1 | |
| SCHEMBL4313069 | 0.76 | GPBAR1 (0.42) | CYP3A4GPBAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7592357-B2 | Compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2009-09-22 | — | — | US | claimed |
| US-20080058384-A1 | Novel Compounds | GLAXOSMITHKLINE LLC | 2008-03-06 | — | — | US | claimed |
| US-7592357-B2 | Compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2009-09-22 | — | — | US | disclosed |
| US-7592357-B2 | Compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2009-09-22 | — | — | US | disclosed |
| US-7592357-B2 | Compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2009-09-22 | — | — | US | disclosed |
| US-20080058384-A1 | Novel Compounds | GLAXOSMITHKLINE LLC | 2008-03-06 | — | — | US | disclosed |
| US-20080058384-A1 | Novel Compounds | GLAXOSMITHKLINE LLC | 2008-03-06 | — | — | US | disclosed |
| US-20080058384-A1 | Novel Compounds | GLAXOSMITHKLINE LLC | 2008-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080058384-A1 | Novel Compounds | ARHGDIB, TNK2, ROCK2 | ROCK1 6/4885CYP3A4 4653/4885CYP2D6 4786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.